Evidence map›Paper›PMID 40087344›Full record

ArticleScientific reports2025

The regulatory role of ACP5 in the diesel exhaust particle-induced AHR inflammatory signaling pathway in a human bronchial epithelial cell line.

Aaron Yu, Dankyu Yoon, Hye Bin An, Uimook Choi, Hye-Ryeon Heo, Dong-Hoon Chae, Hyun Sung Park, Jae Han Park, Myoung Hee Han, Jiyoung Heo and 8 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Aaron Yu *Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Dankyu Yoon *Division of Cardiovascular Disease Research, Department of Chronic Disease Convergence, Korea National Institute of Health, Cheongju, 28159, Korea.
Hye Bin An *Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Uimook ChoiLaboratory of Clinical Immunology and Microbiology, NIAID, NIH, North Bethesda, USA.
Hye-Ryeon HeoDivision of Cardiovascular Disease Research, Department of Chronic Disease Convergence, Korea National Institute of Health, Cheongju, 28159, Korea.
Dong-Hoon ChaeDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Hyun Sung ParkDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Jae Han ParkDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Myoung Hee HanDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Jiyoung HeoDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Keonwoo ChoDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Ki-Sun ParkKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, 34054, Korea.
Hee Min YooBiometrology Group, Korea Research Institute of Standards and Science (KRISS), Daejeon, 34113, Korea.
Hyung-Sik KimDepartment of Life Science in Dentistry, School of Dentistry, Pusan National University, Yangsan, 50612, Korea.
Kyung-Sun KangAdult Stem Cell Research Center and Research, Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Korea.
Mi-Kyung OhDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea.
Hyun Joung LimDivision of Cardiovascular Disease Research, Department of Chronic Disease Convergence, Korea National Institute of Health, Cheongju, 28159, Korea. hjlim1121@korea.kr.
Kyung-Rok YuDepartment of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Korea. cellyu@snu.ac.kr.

Funding

Bio-MAX Institute, Seoul National University 2023 Bio-Connect program (Bio-MAX - BMC)Korea National Institute of Health 2015-NI-67002-00Korea National Institute of Health 2020-NG-010-02Seoul National University 0525-20220151
6 · The paper itself

Abstract

Exposure to diesel exhaust particles (DEPs), which are major constituents of urban air pollution, is associated with adverse health outcomes. Previous studies have shown that DEPs enhance the expression of pro-inflammatory cytokines and immune responses. However, few studies have focused on genomic variants that regulate DEP-induced signaling. Here, we identify a frequently found genomic variant, ACP5, in allergic diseases, and establish an ACP5 knock-out (KO) human bronchial epithelial cell line (BEAS-2B) using CRISPR/Cas9 editing to mimic the ACP5 mutation. DEP-induced apoptosis and intracellular reactive oxygen species (ROS) were significantly increased in the ACP5 KO cells compared with controls, suggesting that ACP5 KO cells were at increased risk from DEP exposure. A gene expression profile revealed an activated aryl hydrocarbon receptor (AHR)-CYP1A1 axis followed by upregulated pro-inflammatory signaling. Treatment of a DEP-exposed ACP5 KO BEAS-2B conditioned medium (CM) supernatant induced an inflammatory response and tissue damage in mice, and AHR inhibition effectively prevented inflammation-induced damage, suggesting that AHR-CYP1A1-inflammatory signaling is a prominent mechanism responsible for detrimental effects. Collectively, our findings reveal a novel link between ACP5 KO and the AHR-CYP1A1 inflammatory signaling pathway in DEP-exposed cells, and identify the AHR-CYP1A1 axis as a potential therapeutic target in individuals suffering from DEP-induced toxicity, particularly those with ACP5 mutations.

Indexed as

Basic Helix-Loop-Helix ProteinsBronchiEpithelial CellsInflammationParticulate MatterReceptors, Aryl HydrocarbonSignal TransductionVehicle EmissionsAnimalsApoptosisCell LineHumansMiceReactive Oxygen SpeciesAHR protein, humanBasic Helix-Loop-Helix ProteinsParticulate MatterReactive Oxygen SpeciesReceptors, Aryl HydrocarbonVehicle EmissionsACP5Aryl hydrocarbon receptorBEAS-2BDiesel exhaust particlesInflammatory response

Identifiers

PMID40087344
PMCPMC11909186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.